Publication | Open Access
Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma
72
Citations
31
References
2017
Year
Our data show that the GMCI/anti-PD-1 combination is well tolerated and effective in glioblastoma mouse models. These results support evaluation of this combination in glioblastoma patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1